GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 71 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 3.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $223,000 | – | 35,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 129,488 | $271,925 | 0.08% |
| Geneos Wealth Management Inc. | 427,400 | $897,540 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $25,200 | 0.02% |
| Vivaldi Capital Management LP | 19,261 | $40,448 | 0.01% |
| Beacon Capital Management, LLC | 12,605 | $26,471 | 0.01% |
| Atria Wealth Solutions, Inc. | 263,300 | $552,930 | 0.01% |
| Wealthspire Advisors, LLC | 183,862 | $386,111 | 0.01% |
| BARRETT & COMPANY, INC. | 4,984 | $10,466 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,271,760 | $2,670,656 | 0.01% |
| Ameritas Advisory Services, LLC | 45,302 | $94,856 | 0.01% |